Other immune cells labelled with CD3, CD4, CD8, CD19, FOXP3, and granzyme B did not show different infiltrations between meningiomas in NF2 patients and sporadic NF2-altered cases (Fig. 4). This evidence concerns the gene CD19 and meningioma.